Mineralys Therapeutics Inc

MLYSNASDAQ · US

Holders

REDUCEDT+30
Congleton Jon
Mineralys Therapeutics Inc · NASDAQ
−75,000 sh · $1.9M
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Slingsby Brian Taylor
Mineralys Therapeutics Inc · NASDAQ
−104,320 sh · $3.0M
Filed 24 Sept 2026SEC Form 4view source
ACQUIREDT+30
Warren Eric
Mineralys Therapeutics Inc · NASDAQ
+7,438 sh · $98.5K
Filed 22 Sept 2026SEC Form 4view source
REDUCEDT+30
Warren Eric
Mineralys Therapeutics Inc · NASDAQ
−7,438 sh · $209.1K
Filed 22 Sept 2026SEC Form 4view source
ACQUIREDT+30
Karydas Daphne
Mineralys Therapeutics Inc · NASDAQ
+3,000 sh · $36.1K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Karydas Daphne
Mineralys Therapeutics Inc · NASDAQ
−3,000 sh · $85.7K
Filed 17 Sept 2026SEC Form 4view source
ACQUIREDStale
Warren Eric
Mineralys Therapeutics Inc · NASDAQ
+7,437 sh · $98.5K
Filed 25 Aug 2026SEC Form 4view source
REDUCEDStale
Warren Eric
Mineralys Therapeutics Inc · NASDAQ
−7,437 sh · $193.2K
Filed 25 Aug 2026SEC Form 4view source
DISCLOSEDStale
Renaissance Technologies
Mineralys Therapeutics Inc · NASDAQ
382,800 sh · $10.4M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Mineralys Therapeutics Inc · NASDAQ
311,488 sh · $8.4M
Filed 31 Mar 2026SEC 13Fview source